Phase I Clinical Study of the Subunit Betulin-Adjuvanted Tetravalent Candidate Influenza Vaccine TetraFluBet

Objectives: This study aimed to determine the safety, tolerability and immunogenicity of TetraFluBet, an inactivated subunit influenza vaccine that contains a corpuscular immuno-adjuvant derived from natural betulin. Methods: We conducted a prospective, randomized, open-labeled, single-center, phase...

Cijeli opis

Bibliografski detalji

Glavni autori:	Igor Krasilnikov, Irina Tcymbarevich, Anna Krasheninnikova, Maria Sukhova, Aleksandr Ivanov, Marina Stukova, Ekaterina Romanovskaya-Romanko, Tatiana Zubkova, Aleksandr Mironov, Dmitriy Lioznov
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2024-09-01
Serija:	Vaccines
Teme:	influenza vaccine seasonal influenza pandemic influenza adjuvant subunit vaccine betulin
Online pristup:	https://www.mdpi.com/2076-393X/12/9/1017
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!